Minneapolis Star Tribune, February 6, 2012

Medical device firms across Minnesota have invested millions to develop products to heal open wounds, a $1.8 billion market that is expected to grow as the population ages and the number of people with type 2 diabetes climbs. But many of these companies are struggling to get their treatments to the masses because insurance companies often refuse to pay for their products.
Facebook icon
LinkedIn icon
Twitter icon